September 29, 2009 - The Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure) announced plans to develop a proton therapy center in the Pacific Northwest.
SCCA and ProCure said the project aims to bring proton therapy advanced to adult and pediatric cancer patients. In fact, the SCCA was formed to accelerate the development and evaluation of new therapies for cancer, and said it considers proton therapy a compelling treatment for pediatric and many adult cancer patients, since the beam is precisely deposited in the tumor, sparing healthy tissue and reducing side effects. Children can reportedly benefit significantly from proton therapy because their bodies are more vulnerable to the side effects of radiation treatment.
The SCCA proton center will be built on the campus of Northwest Hospital & Medical Center in north Seattle. When completed, the proton center will primarily serve a five-state region, and like other clinical programs at the SCCA, it will attract patients nationally and internationally. The proton center will treat approximately 1,400 patients per year in a 60,000-square-foot facility.
ProCure collaborates with hospitals, health systems and physician groups to develop and operate proton therapy centers.
For more information: www.seattlecca.org and www.procure.com
May 06, 2024 
